Status:
COMPLETED
Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis
Lead Sponsor:
Zhujiang Hospital
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
65+ years
Phase:
PHASE1
PHASE2
Brief Summary
In this single-center, randomized, single-blind, placebo-controlled pilot clinical trial. The effect of apigenin on the improvement of organ function will be investigated in elderly patients with seps...
Detailed Description
Investigational drug: Apigenin Study title: Improvement of Organ function by Apigenin in Elderly Patients With Sepsis: A Single-center, Single-blind, Randomized, Placebo-controlled, pilot Clinical Tri...
Eligibility Criteria
Inclusion
- age ≥65 years;
- meeting the diagnostic criteria of the 2016 International Sepsis Guidelines;
- subjects who voluntarily participated in this study and signed an informed consent form.
Exclusion
- patients who are allergic to the study products;
- patients who are unable to feed via gastrointestinal nutrition tube.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 5 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05999682
Start Date
September 1 2023
End Date
January 5 2024
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University
Guanzhou, Guangdong, China